118
Views
0
CrossRef citations to date
0
Altmetric
Review

Addressing The Barriers Related With Opioid Therapy For Management of Chronic Pain in India

, , , , , & show all
Pages 311-330 | Received 20 Dec 2016, Accepted 12 Feb 2017, Published online: 12 Jul 2017

References

  • Sofat N , EjinduV , KielyP . What makes osteoarthritis painful? The evidence for local and central pain processing . Rheumatology50 , 2157 – 2165 ( 2011 ).
  • Johanson GA . Symptom character and prevalence during cancer patients’ last days of life . Am. J. Hospice Palliat. Med.8 , 6 – 7 ( 1991 ).
  • Breitbart W , McDonaldMV , RosenfeldBet al. Pain in ambulatory AIDS patients. I: pain characteristics and medical correlates . Pain68 , 315 – 321 ( 1996 ).
  • Clauw DJ . Fibromyalgia: an overview . Am. J. Med.122 , S3 – S13 ( 2009 ).
  • Breivik H , CollettB , VentafriddaV , CohenR , GallacherD . Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment . Eur. J. Pain10 , 287 – 333 ( 2006 ).
  • Brennan F , CarrDB , CousinsM . Pain management: a fundamental human right . Anesth. Analg.105 , 205 – 221 ( 2007 ).
  • Moulin D , AmirehR , SharpeW , BoydD , MerskeyH , IezziA . Randomised trial of oral morphine for chronic non-cancer pain . Lancet347 , 143 – 147 ( 1996 ).
  • WHO Resolution (WHO-WHA67.19) . Strengthening of palliative care as a component of comprehensive care throughout the life course ( 2014 ). http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R19-en.pdf .
  • Human Rights Watch . Global state of pain treatment: access to medicines and palliative care ( 2011 ). https://www.hrw.org/report/2011/06/02/global-state-pain-treatment/access-medicines-and-palliative-care#8d05bc .
  • Dureja GP , JainPN , ShettyNet al. Prevalence of chronic pain, impact on daily life, and treatment practices in India . Pain Pract.14 , E51 – E62 ( 2014 ).
  • Watson CPN , MoulinD , Watt-WatsonJ , GordonA , EisenhofferJ . Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy . Pain105 , 71 – 78 ( 2003 ).
  • Peloso PM , BellamyN , BensenWet al. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee . J. Rheumatol.27 , 764 – 771 ( 2000 ).
  • Saxena AK , NasareN , JainSet al. A randomized, prospective study of efficacy and safety of oral tramadol in the management of post-herpetic neuralgia in patients from North India . Pain Pract.13 , 264 – 275 ( 2013 ).
  • Kissin I . Scientometric assessment of drugs for chronic pain, 1979–2013: rapid growth of publications, paucity of successful drugs . J. Pain Res.7 , 505 – 514 ( 2014 ).
  • Jacob A , MathewA . End-of-life care and opioid use in India: challenges and opportunities . J. Glob. Oncol. DOI: 10.1200/JGO.2016.008490 ( 2017 ) ( Epub ahead of print ).
  • Maltoni M . Opioids, pain, and fear . Ann. Oncol.19 , 5 – 7 ( 2008 ).
  • Blake H , LeightonP , van der WaltG , RavenscroftA . Prescribing opioid analgesics for chronic non-malignant pain in general practice–a survey of attitudes and practice . Br. J. Pain.9 , 225 – 232 ( 2015 ).
  • Rietman JS , DijkstraPU , DebreczeniR , GeertzenJHB , RobinsonDPH , de VriesJ . Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery . Disabil. Rehabil.26 , 78 – 84 ( 2004 ).
  • Cleeland CS , GoninR , BaezL , LoehrerP , PandyaKJ . Pain and treatment of pain in minority patients with cancer: the Eastern cooperative oncology group minority outpatient pain study . Ann. Intern. Med.127 , 813 – 816 ( 1997 ).
  • van den Beuken-van Everdingen M , de RijkeJ , KesselsA , SchoutenH , van KleefM , PatijnJ . Prevalence of pain in patients with cancer: a systematic review of the past 40 years . Ann. Oncol.18 , 1437 – 1449 ( 2007 ).
  • Foley KM . How well is cancer pain treated?Palliat. Med.25 , 398 – 401 ( 2011 ).
  • Wiffen PJ , McQuayHJ . Oral morphine for cancer pain . Cochrane Database Syst. Rev.4 , CD003868 ( 2007 ).
  • Wiffen PJ , WeeB , MooreRA . Oral morphine for cancer pain . Cochrane Database Syst. Rev.7 , CD003868 ( 2013 ).
  • Schmidt-Hansen M , BennettMI , ArnoldS , BromhamN , HilgartJS . Oxycodone for cancer-related pain . Cochrane Database Syst. Rev.2 , CD003870 ( 2015 ).
  • Hadley G , DerryS , MooreRA , WiffenPJ . Transdermal fentanyl for cancer pain . Cochrane Database Syst. Rev.10 , CD010270 ( 2013 ).
  • Straube C , DerryS , JacksonKCet al. Codeine, alone and with paracetamol (acetaminophen), for cancer pain . Cochrane Database Syst. Rev.9 , CD006601 ( 2014 ).
  • World Health Organization . Cancer Pain Relief . World Health Organization , Geneva, Switzerland ( 1996 ). http://apps.who.int/iris/bitstream/10665/37896/1/9241544821.pdf .
  • World Health Organization . WHO guidelines on pharmacological treatment of persisting pain in children with medical illnesses ( 2012 ). http://apps.who.int/iris/bitstream/10665/44540/1/9789241548120_Guidelines.pdf .
  • WHO . Essential medicines in palliative care ( 2013 ). http://www.who.int/selection_medicines/committees/expert/19/applications/PalliativeCare_8_A_R.pdf .
  • Vargas-Schaffer G . Is the WHO analgesic ladder still valid? Twenty-four years of experience . Can. Fam. Physician56 , 514 – 517 ( 2010 ).
  • Ripamonti CI , SantiniD , MaranzanoE , BertiM , RoilaF , ESMO Guidelines Working Group . Management of cancer pain: ESMO clinical practice guidelines . Ann. Oncol.23 , vii139 – vii154 ( 2012 ).
  • Caraceni A , HanksG , KaasaSet al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC . Lancet Oncol.13 , e58 – e68 ( 2012 ).
  • Orhan ME , BilginF , ErginA , DereK , GüzeldemirME . Pain treatment practice according to the WHO analgesic ladder in cancer patients: eight years experience of a single center . Agri20 , 37 – 43 ( 2008 ).
  • Zech DF , GrondS , LynchJ , HertelD , LehmannKA . Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study . Pain63 , 65 – 76 ( 1995 ).
  • Cleeland CS , GoninR , HatfieldAKet al. Pain and its treatment in outpatients with metastatic cancer . NEJM330 , 592 – 596 ( 1994 ).
  • Greco MT , RobertoA , CorliOet al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer . J. Clin. Oncol.32 , 4149 – 4154 ( 2014 ).
  • Radbruch L , LehmannK , GockelH-H , NeighborsD , NuytsG . Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine . Eur. J. Health Econ.3 , 111 – 119 ( 2002 ).
  • DeLeo JA . Basic science of pain . J. Bone Joint Surg. Am.88 , 58 – 62 ( 2006 ).
  • Chou R , FanciulloGJ , FinePGet al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain . J. Pain.10 , 113 – 130 ( 2009 ).
  • National Opioid Use Guideline Group . Canadian guideline for safe and effective use of opioids for chronic non-cancer pain ( 2010 ). http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_b_v5_6.pdf .
  • Kalso E , EdwardsJE , MooreRA , McQuayHJ . Opioids in chronic non-cancer pain: systematic review of efficacy and safety . Pain112 , 372 – 380 ( 2004 ).
  • Zenz M , StrumpfM , TrybaM . Long-term oral opioid therapy in patients with chronic nonmalignant pain . J. Pain Symptom Manage.7 , 69 – 77 ( 1992 ).
  • Fishbain DA , ColeB , LewisJ , RosomoffHL , RosomoffRS . What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review . Pain Med.9 , 444 – 459 ( 2008 ).
  • George JM , MenonM , GuptaP , TanM . Use of strong opioids for chronic non-cancer pain: a retrospective analysis at a pain centre in Singapore . Singapore Med. J.54 , 506 – 510 ( 2013 ).
  • Noble M , TreadwellJR , TregearSJet al. Long-term opioid management for chronic noncancer pain . Cochrane Database Syst. Rev.1 , CD006605 ( 2010 ).
  • Chou R , BallantyneJC , FanciulloGJ , FinePG , MiaskowskiC . Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline . J. Pain10 , 147 – 159 ( 2009 ).
  • Freynhagen R , GeisslingerG , SchugSA . Opioids for chronic non-cancer pain . BMJ346 , f2937(2013 ).
  • Chan BKB , TamLK , WatCY , ChungYF , TsuiSL , CheungCW . Opioids in chronic non-cancer pain . Expert Opin. Pharmacother.12 , 705 – 720 ( 2011 ).
  • Furlan AD , SandovalJA , Mailis-GagnonA , TunksE . Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects . CMAJ174 , 1589 – 1594 ( 2006 ).
  • Sindrup SH , OttoM , FinnerupNB , JensenTS . Antidepressants in the treatment of neuropathic pain . Basic Clin. Pharmacol. Toxicol.96 , 399 – 409 ( 2005 ).
  • Dworkin RH , O’connorAB , BackonjaMet al. Pharmacologic management of neuropathic pain: evidence-based recommendations . Pain132 , 237 – 251 ( 2007 ).
  • Baron R , KernU , MüllerM , DuboisC , FalkeD , SteigerwaldI . Effectiveness and tolerability of a moderate dose of tapentadol prolonged release for managing severe, chronic low back pain with a neuropathic component: an open-label continuation arm of a randomized Phase 3b study . Pain Pract.15 , 471 – 486 ( 2015 ).
  • Schwartz S , EtropolskiM , ShapiroDYet al. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial . Curr. Med. Res. Opin.27 , 151 – 162 ( 2011 ).
  • Vinik AI , ShapiroDY , RauschkolbCet al. A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy . Diabetes Care37 , 2302 – 2309 ( 2014 ).
  • Ho KY , ChuaN , GeorgeJMet al. Evidence-based guidelines on the use of opioids in chronic non-cancer pain – a consensus statement by the Pain Association of Singapore Task Force . Ann. Acad. Med. Singapore42 , 138 – 152 ( 2013 ).
  • Chou R , TurnerJA , DevineEBet al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop . Ann. Intern. Med.162 , 276 – 286 ( 2015 ).
  • Stewart WF , RicciJA , CheeE , MorgansteinD , LiptonR . Lost productive time and cost due to common pain conditions in the US Workforce . JAMA290 , 2443 – 2454 ( 2003 ).
  • Leeuwen MT , BlythFM , MarchLM , NicholasMK , CousinsMJ . Chronic pain and reduced work effectiveness: the hidden cost to Australian employers . Eur. J. Pain.10 , 161 – 161 ( 2006 ).
  • Economics of Non-Communicable Diseases in India . A report by the World Economic Forum and the Harvard School of Public Health ( 2014 ). http://iogt.org/wp-content/uploads/2015/03/WEF_EconomicNonCommunicableDiseasesIndia_ExecutiveSummary_2014.pdf .
  • Blyth FM , MarchLM , CousinsMJ . Chronic pain-related disability and use of analgesia and health services in a Sydney community . Med. J. Aust.179 , 84 – 87 ( 2003 ).
  • Bhatnagar S . Freedom from Pain (Sixteenth International Conference of Indian Association of Palliative Care) . I. K. International Pvt. Ltd. New Dehli, India ( 2009 ).
  • Goucke R . Chronic pain management: guidelines for multidisciplinary program development . Anaesth. Intensive Care.37 , 870 – 871 ( 2009 ).
  • Devulder J , RicharzU , NatarajaS . Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain . Curr. Med. Res. Opin.21 , 1555 – 1568 ( 2005 ).
  • Dhawan A , ChopraA . Does buprenorphine maintenance improve the quality of life of opioid users?Indian J. Med. Res.137 , 130 ( 2013 ).
  • Dillie KS , FlemingMF , MundtMP , FrenchMT . Quality of life associated with daily opioid therapy in a primary care chronic pain sample . J. Am. Board Fam. Med.21 , 108 – 117 ( 2008 ).
  • Soin A , ChengJ , BrownL , MoufawadS , MekhailN . Functional outcomes in patients with chronic nonmalignant pain on long-term opioid therapy . Pain Pract.8 , 379 – 384 ( 2008 ).
  • Obradovic M , IkenbergR , HertelN , AntoñanzasF , GálvezR , LiedgensH . Cost-effectiveness of tapentadol in severe chronic pain in Spain: a cost analysis of data from RCTs . Clin. Ther.34 , 926 – 943 ( 2012 ).
  • Neighbors DM , BellTJ , WilsonJ , DoddSL . Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain . J. Pain Symptom Manage.21 , 129 – 143 ( 2001 ).
  • Greiner W , LehmannK , EarnshawS , BugC , SabatowskiR . Economic evaluation of durogesic in moderate to severe, nonmalignant, chronic pain in Germany . Eur. J. Health Econ.7 , 290 – 296 ( 2006 ).
  • Trescot AM , DattaS , LeeM , HansenH . Opioid pharmacology . Pain Physician11 , S133 – S153 ( 2008 ).
  • Martin WR . History and development of mixed opioid agonists, partial agonists and antagonists . Br. J. Clin. Pharmacol.7 , 273S – 279S ( 1979 ).
  • McPherson J , RiveroG , BaptistMet al. μ-Opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization . Mol. Pharmacol.78 , 756 – 766 ( 2010 ).
  • Bailey CP , ConnorM . Opioids: cellular mechanisms of tolerance and physical dependence . Curr. Opin. Pharmacol.5 , 60 – 68 ( 2005 ).
  • Nasare NV , DeshmukhPS , BanerjeeBDet al. CYP2D6* 4 polymorphism, tramadol treatment and its clinical impact in patients with postherpetic neuralgia . Personal. Med.9 , 371 – 385 ( 2012 ).
  • Corbett AD , HendersonG , McKnightAT , PatersonSJ . 75 years of opioid research: the exciting but vain quest for the Holy Grail . Br. J. Pharmacol.147 , S153 – S162 ( 2006 ).
  • Katzung BG , MastersSB , TrevorAJ . Basic & Clinical Pharmacology . Lange Medical Books/McGraw-Hill , NY, USA ( 2004 ).
  • Stimmel B . Addiction Potential of Abused Drugs and Drug Classes . Routledge, NY, USA ( 2013 ).
  • Dayer P , CollartL , DesmeulesJ . The pharmacology of tramadol . Drugs47 , 3 – 7 ( 1994 ).
  • UK Medicines Information (UKMi): medicines Q&As for NHS healthcare professionals . http://www.ukmi.nhs.uk/activities/medicinesqas/ .
  • Pradhan AA , BefortK , NozakiC , Gavériaux-RuffC , KiefferBL . The delta opioid receptor: an evolving target for the treatment of brain disorders . Trends Pharmacol. Sci.32 , 581 – 590 ( 2011 ).
  • Vanderah TW . Delta and kappa opioid receptors as suitable drug targets for pain . Clin. J. Pain26 , S10 – S15 ( 2010 ).
  • Hanks GW , De ConnoF , RipamontiC , VentafriddaV . Morphine in cancer pain: modes of administration . BMJ312 , 823 – 826 ( 1996 ).
  • Narabayashi M , SaijoY , TakenoshitaSet al. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial . Jpn J. Clin. Oncol.38 , 296 – 304 ( 2008 ).
  • Palangio M , MorrisE , DoyleRT , DornseifBE , ValenteTJ . Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain . Clin. Ther.24 , 87 – 99 ( 2002 ).
  • Marco CA , PlewaMC , BudererN , BlackC , RobertsA . Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: a double-blind, randomized, controlled trial . Acad. Emerg. Med.12 , 282 – 288 ( 2005 ).
  • Hanks G , De ConnoF , ChernyNet al. Morphine and alternative opioids in cancer pain: the EAPC recommendations: Expert Working Group of the Research Network of the European Association for Palliative Care . Br. J. Cancer.84 , 587 ( 2001 ).
  • Muijsers RB , WagstaffAJ . Transdermal fentanyl . Drugs61 , 2289 – 2307 ( 2001 ).
  • Allan L , HaysH , JensenN-Het al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain . BMJ322 , 1154 ( 2001 ).
  • Ahmedzai S , BrooksD , TTS-Fentanyl Comparative Trial Group . Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life . J. Pain Symptom Manage.13 , 254 – 261 ( 1997 ).
  • Quigley C . The role of opioids in cancer pain . BMJ331 , 825 – 829 ( 2005 ).
  • Saxena AK , AravaSK . Current concepts in neuraxial administration of opioids and non-opioids: an overview and future perspectives . Indian J. Anaesth.48 , 13 – 24 ( 2004 ).
  • Smith H , PassikS . Pain and Chemical Dependency . Oxford University Press , Oxford, UK ( 2008 ).
  • Human Rights Watch . Unbearable Pain- India’s obligation to ensure palliative care: The Human Rights Watch Report ( 2009 ). https://www.hrw.org/sites/default/files/reports/health1009web.pdf .
  • Keshari SS , KesarwaniP , MiliM . Prevalence and pattern of self-medication practices in rural area of Barabanki . Community Medicine, Ind. J. Clin. Pract.25 ( 2014 ).
  • Selvaraj K , KumarSG , RamalingamA . Prevalence of self-medication practices and its associated factors in Urban Puducherry, India . Perspect. Clin. Res.5 , 32 – 36 ( 2014 ).
  • Kumar A . Organization and development of pain clinics and palliative care in developing countries . Eur. J. Anaesthesiol.21 , 169 – 172 ( 2004 ).
  • Free MM . Cross-cultural conceptions of pain and pain control . Baylor University Medical Center. Proceedings.15 , 143 ( 2002 ).
  • Pillay T , van ZylHA , BlackbeardD . Chronic pain perception and cultural experience . Procedia Soc. Behav. Sci.113 , 151 – 160 ( 2014 ).
  • Ahmad A , PatelI , MohantaGP , BalkrishnanR . Evaluation of self medication practices in rural area of town Sahaswan at Northern India . Ann. Med. Health Sci. Res.4 , S73 – S78 ( 2014 ).
  • Wildner-Christensen M , HansenJM , De MuckadellOBS . Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection . Scand. J. Gastroenterol.41 , 149 – 154 ( 2006 ).
  • Ruszniewski P , SouffletC , BarthelemyP . Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study . Alimentary Pharmacol. Ther.28 , 1134 – 1139 ( 2008 ).
  • Huerta C , CastellsagueJ , Varas-LorenzoC , García RodríguezLA . Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population . Am. J. Kidney Dis.45 , 531 – 539 ( 2005 ).
  • Over 4mn Indians could be living with chronic joint pain . The Indian Express ( 2014 ). http://indianexpress.com/article/explained/over-4-mn-indians-could-be-living-with-chronic-joint-pain/ .
  • Berterame S , ErthalJ , ThomasJet al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study . Lancet387 , 1644 – 1656 ( 2016 ).
  • Seya MJ , GeldersSF , AcharaOU , MilaniB , ScholtenWK . A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels . J. Pain Palliat. Care Pharmacother.25 , 6 – 18 ( 2011 ).
  • Duthey B , ScholtenW . Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006 . J. Pain Symptom Manage.47 , 283 – 297 ( 2014 ).
  • Rajagopal M , JoransonDE . India: opioid availability – an update . J. Pain Symptom Manage.33 , 615 – 622 ( 2007 ).
  • Narcotics Control Bureau ( 2016 ). http://narcoticsindia.nic.in/about.php .
  • Narcotics control . Gazette notification by Ministry of Finance, Government of India ( 2015 ). http://palliumindia.org/cms/wp-content/uploads/2014/01/Gazette-Notification-No.285-regarding-NDPS-State-Rules-and-Procedures-dated-05–05–2015.pdf .
  • The Narcotic Drugs and Psychotropic Substances (Amendment) Bill ( 2011 ). http://www.prsindia.org/uploads/media/Narcotic%20Drugs/The%20Narcotic%20Drugs%20and%20Psychotropic%20Substances%20Amendment%20Bill%202011.pdf .
  • The Narcotic Substances and Psychotropic Substances Act – India ( 1985 ). http://narcoticsindia.nic.in/upload/download/document_id08b2dbdc9ca941d237893bd425af8bfa.pdf .
  • The Narcotic Drugs and Psychotropic Substances (Amendment) Act ( 1988 ). http://lawmin.nic.in/legislative/textofcentralacts/1989.pdf .
  • The Narcotic Drugs and Psychotropic Substances (Amendment) Act ( 2014 ). %%%www.mpsja.mphc.gov.in/Joti/pdf/LU/NDPS%20SINGH%20SIR.docx%20corrected.pdf .
  • Narcotic Drugs and Psychotropic Substances (Third Amendment) Rules ( 2015 ). http://palliumindia.org/cms/wp-content/uploads/2014/01/Gazette-Notification-No.285-regarding-NDPS-State-Rules-and-Procedures-dated-05–05–2015.pdf .
  • Ray R , ChopraA . Monitoring of substance abuse in India – Initiatives & experiences . Indian J. Med. Res.135 , 806 – 808 ( 2012 ).
  • Degenhardt L , CharlsonF , MathersBet al. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study . Addiction109 , 1320 – 1333 ( 2014 ).
  • National survey on extent, pattern and trends of drug abuse in India . United Nations Office on Drugs and Crime ( 2004 ). http://www.unodc.org/pdf/india/presentations/india_national_survey_2004.pdf .
  • Müller-Schwefe G , JakschW , MorlionBet al. Make a CHANGE: optimising communication and pain management decisions . Curr. Med. Res. Opin.27 , 481 – 488 ( 2011 ).
  • Von Roenn JH , CleelandCS , GoninR , HatfieldAK , PandyaKJ . Physician attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group . Ann. Intern. Med.119 , 121 – 126 ( 1993 ).
  • Wolfert MZ , GilsonAM , DahlJL , ClearyJF . Opioid analgesics for pain control: Wisconsin physicians’ knowledge, beliefs, attitudes, and prescribing practices . Pain Med.11 , 425 – 434 ( 2010 ).
  • Keller CE , AshrafiounL , NeumannAM , Van KleinJ , FoxCH , BlondellRD . Practices, perceptions, and concerns of primary care physicians about opioid dependence associated with the treatment of chronic pain . Subst. Abus.33 , 103 – 113 ( 2012 ).
  • Hutchinson K , MorelandAM , WilliamsAC , WeinmanJ , HorneR . Exploring beliefs and practice of opioid prescribing for persistent non-cancer pain by general practitioners . Eur. J. Pain.11 , 93 ( 2007 ).
  • Gielen J , GuptaH , RajvanshiAet al. The attitudes of Indian palliative-care nurses and physicians to pain control and palliative sedation. Indian J. Palliat. Care 17 , 33 ( 2011 ).
  • Bakshi SG , JainPN , KannanS . An assessment of basic pain knowledge and impact of pain education on Indian Anaesthesiologists-a pre and post questionnaire study . Indian J. Anaesth.58 , 127 ( 2014 ).
  • Bhadra K , ManirKS , AdhikaryAet al. Awareness of palliative care among doctors of various departments in all the four teaching medical colleges in a metropolitan city in Eastern India: a survey . J. Med. Soc.27 , 114 ( 2013 ).
  • Cleary J , SimhaN , PanieriAet al. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in India: a report from the Global Opioid Policy Initiative (GOPI) . Ann. Oncol.24 , xi33 – xi40 ( 2013 ).
  • Wadhwa R , ChilkotiG , SaxenaAK . Current clinical opinions, attitudes and awareness of interns regarding post-operative and cancer pain management in a tertiary care centre . Indian J. Palliat. Care.21 , 49 – 55 ( 2015 ).
  • Tournebize J , GibajaV , MuszczakA , KahnJP . Are physicians safely prescribing opioids for chronic noncancer pain? A systematic review of current evidence . Pain Pract.16 , 370 – 383 ( 2015 ).
  • Trescot AM , BoswellMV , AtluriSLet al. Opioid guidelines in the management of chronic non-cancer pain . Pain Physician9 , 1 ( 2006 ).
  • Spitz A , MooreAA , PapaleontiouM , GranieriE , TurnerBJ , ReidM . Primary care providers’ perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study . BMC Geriatr.11 , 1 ( 2011 ).
  • Thota RS , JainP , BakshiSG , DhanveCN . Opioid-prescribing practices in chronic cancer pain in a tertiary care pain clinic . Indian J. Palliat. Care.17 , 222 ( 2011 ).
  • World Health Organization . Ensuring balance in national policies on controlled substances ( 2010 ). http://apps.who.int/iris/bitstream/10665/44519/1/9789241564175_eng.pdf .
  • Zallman L , RubensSL , SaitzR , SametJH , Lloyd-TravagliniC , LiebschutzJ . Attitudinal barriers to analgesic use among patients with substance use disorders . Pain Res. Treat.2012 , 167062 ( 2012 ).
  • Hill CS . The barriers to adequate pain management with opioid analgesics . Semin. Oncol.20 , 1 – 5 ( 1993 ).
  • Glajchen M . Chronic pain: treatment barriers and strategies for clinical practice . J. Am. Board Fam. Pract.14 , 211 – 218 ( 2001 ).
  • Ward SE , GoldbergN , Miller-McCauleyVet al. Patient-related barriers to management of cancer pain . Pain52 , 319 – 324 ( 1993 ).
  • Yates PM , EdwardsHE , NashREet al. Barriers to effective cancer pain management: a survey of hospitalized cancer patients in Australia . J. Pain Symptom Manage.23 , 393 – 405 ( 2002 ).
  • Breitbart W , PassikS , McDonaldMVet al. Patient-related barriers to pain management in ambulatory AIDS patients . Pain76 , 9 – 16 ( 1998 ).
  • Fitzcharles M-A , DaCostaD , WareMA , ShirY . Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis . J. Pain10 , 300 – 305 ( 2009 ).
  • Potter VT , WisemanCE , DunnSM , BoyleFM . Patient barriers to optimal cancer pain control . Psycho-Oncology12 , 153 – 160 ( 2003 ).
  • Jovey R , EnnisJ , Gardner-NixJet al. Use of opioid analgesics for the treatment of chronic noncancer pain – a consensus statement and guidelines from the Canadian Pain Society, 2002 . Pain Res. Manag.8 , 3A – 28A ( 2003 ).
  • CDC Guideline for Prescribing Opioids for Chronic Pain ( 2016 ). http://www.cdc.gov/drugoverdose/prescribing/providers.html .
  • Hooten W , TimmingR , BelgradeMet al. Assessment and management of chronic pain . Inst. Clin. Syst. Improv.106 ( 2013 ).
  • Gourlay DL , HeitHA , AlmahreziA . Universal precautions in pain medicine: a rational approach to the treatment of chronic pain . Pain Med.6 , 107 – 112 ( 2005 ).
  • Saxena AK , KumarS . Management strategies for pain in breast carcinoma patients: current opinions and future perspectives . Pain Pract.7 , 163 – 177 ( 2007 ).
  • Jamison RN , SerraillierJ , MichnaE . Assessment and treatment of abuse risk in opioid prescribing for chronic pain . Pain Res. Treat.2011 , Article ID 941808 ( 2011 ).
  • INCB report 2010 . www.incb.org/documents/Publications/AnnualReports/AR2010/AR_2010_English.pdfINCB .
  • INCB report 2014 . www.incb.org/documents/Publications/AnnualReports/AR2014/English/AR_2014.pdf .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.